Literature DB >> 7058804

Bacterial contamination of aerosol solutions used to treat cystic fibrosis.

R J Kuhn, A H Lubin, P R Jones, M C Nahata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7058804

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN： 0002-9289


× No keyword cloud information.
  5 in total

1.  Aerosolization of lipoplexes using AERx Pulmonary Delivery System.

Authors:  Deepa Deshpande; James Blanchard; Sudarshan Srinivasan; Dallas Fairbanks; Jun Fujimoto; Teiji Sawa; Jeanine Wiener-Kronish; Hans Schreier; Igor Gonda
Journal:  AAPS PharmSci       Date:  2002

2.  Adverse reactions to the non-drug constituents of nebuliser solutions.

Authors:  R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

3.  Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis.

Authors:  G R Hutchinson; S Parker; J A Pryor; F Duncan-Skingle; P N Hoffman; M E Hodson; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 4.  The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.

Authors:  O C Tablan; W J Martone; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

5.  Bacterial Surface Detachment during Nebulization with Contaminated Reusable Home Nebulizers.

Authors:  Jamie C Harris; Melanie S Collins; Pamela H Huang; Craig M Schramm; Thomas Nero; Jing Yan; Thomas S Murray
Journal:  Microbiol Spectr       Date:  2022-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.